Financials Nanjing Vishee Medical Technology Co., Ltd

Equities

688580

CNE1000041Q0

Advanced Medical Equipment & Technology

End-of-day quote Shanghai S.E. 23:00:00 09/05/2024 BST 5-day change 1st Jan Change
46.87 CNY -3.42% Intraday chart for Nanjing Vishee Medical Technology Co., Ltd +2.14% -26.69%

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 6,945 7,436 3,651 4,361 3,193 - -
Enterprise Value (EV) 1 6,945 7,436 3,651 4,361 3,193 3,193 3,193
P/E ratio 41.3 x 41.9 x 38.7 x 32.1 x 18.6 x 15.1 x 13.1 x
Yield - - 1.29% 2.35% 3.83% 4.62% 6.04%
Capitalization / Revenue 18.4 x 17.3 x 11.4 x 9.44 x 5.58 x 4.59 x 3.93 x
EV / Revenue 18.4 x 17.3 x 11.4 x 9.44 x 5.58 x 4.59 x 3.93 x
EV / EBITDA 39.9 x 36.1 x 29.9 x 25.8 x 15.6 x 13 x 10.9 x
EV / FCF - - - - - - -
FCF Yield - - - - - - -
Price to Book 4.94 x 4.85 x 2.39 x 2.7 x 1.85 x 1.73 x 1.56 x
Nbr of stocks (in thousands) 68,347 68,347 68,624 68,222 68,122 - -
Reference price 2 101.6 108.8 53.20 63.93 46.87 46.87 46.87
Announcement Date 22/02/21 21/01/22 22/02/23 26/02/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 318.9 378.4 430 321.6 462.2 571.9 695.1 811.8
EBITDA 1 - 173.9 205.8 122.1 169.2 204 245.1 292.9
EBIT 1 - 164.9 194.7 104.5 148.4 198 238.9 276.5
Operating Margin - 43.57% 45.27% 32.48% 32.11% 34.62% 34.37% 34.06%
Earnings before Tax (EBT) 1 - 166.1 197.4 105.8 150 198.2 239.4 277
Net income 1 - 143.7 177.8 93.83 136.3 172.8 212.9 246.5
Net margin - 37.97% 41.35% 29.17% 29.48% 30.22% 30.63% 30.37%
EPS 2 - 2.460 2.594 1.373 1.994 2.518 3.102 3.590
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 - - - 0.6876 1.503 1.795 2.165 2.830
Announcement Date 30/06/20 22/02/21 21/01/22 22/02/23 26/02/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period:
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) - 19.7% 12.2% 6.13% 8.63% 10% 11.5% 12.1%
ROA (Net income/ Total Assets) - - 10.9% 5.65% 7.82% 9.45% 10.9% 12.3%
Assets 1 - - 1,638 1,660 1,743 1,829 1,962 2,004
Book Value Per Share 2 - 20.60 22.40 22.30 23.70 25.30 27.20 30.00
Cash Flow per Share 2 - 1.770 2.300 1.260 1.960 2.220 3.010 3.940
Capex 1 - 11.6 87.3 95.6 133 111 68.3 124
Capex / Sales - 3.06% 20.31% 29.73% 28.88% 19.49% 9.82% 15.27%
Announcement Date 30/06/20 22/02/21 21/01/22 22/02/23 26/02/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
46.87 CNY
Average target price
62 CNY
Spread / Average Target
+32.28%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688580 Stock
  4. Financials Nanjing Vishee Medical Technology Co., Ltd